Your session is about to expire
← Back to Search
cPMD rTMS + Training for Stroke
Study Summary
This trialwill create new therapies to help stroke survivors with severe upper limb disabilities.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are in good health and your medical condition is under control.You have significant weakness or reduced function in your arms and/or legs (UEFM score of 42 or less).
- Group 1: cPMD rTMS + Training
- Group 2: iM1 rTMS + Training
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being welcomed into this clinical experiment?
"Correct. Clinicaltrials.gov confirms that this research project, which was first posted on April 1st 2019, is actively accepting applications from participants. 24 individuals are required to be enrolled from a single medical centre."
Are there any opportunities for me to participate in this clinical investigation?
"In order to be accepted into this research trial, candidates need to have had a stroke and must fall within the 18-90 year old age range. Currently, 24 participants are being recruited."
What concrete outcomes is this study attempting to discern?
"The primary endpoint that will be examined over the duration of this study (on average 7 weeks) is a change in Upper Extremity Fugyl-Meyer Score. Secondary objectives include changes to diffusion tensor imaging, resting state functional magnetic resonance imaging, and reaching response time. These metrics help quantify neurophysiological interactions between contralesional and weak ipsilesional regions as well as global connectivity across multiple areas by tracking water magnitudes and directions through probabilistic tractography while also measuring white matter integrity with fractional anisotropy."
Does this clinical trial accept participants aged under 25?
"This trial is open to individuals aged between 18 and 90. For those outside of this age range, 37 studies are available for minors while 1006 trials target the elderly population."
Are there any opportunities for enrollees in the current clinical experiment?
"Affirmative. The clinical trial database hosted on clinicaltrials.gov verifies that this medical experiment is currently accepting enrolments and was first advertised to the public on April 1st 2019, with its most recent update occurring November 15th 2022. It's expected that 24 persons will be recruited at a single medical location for study involvement."
Share this study with friends
Copy Link
Messenger